[Federal Register Volume 66, Number 64 (Tuesday, April 3, 2001)]
[Notices]
[Page 17719]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-8062]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Consumer Briefing on Bovine Spongiform Encephalopathy (BSE) and 
Transmissible Spongiform Encephalopathies (TSE)

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing the following 
consumer meeting: Consumer Briefing on Bovine Spongiform Encephalopathy 
(BSE) and Transmissible Spongiform Encephalopathies (TSE). This 
briefing is the first in a series of consumer briefings on the consumer 
protection priorities discussed by the agency and consumers at the 
December 13, 2000, Consumer Roundtable on Consumer Protection 
Priorities meeting. These consumer briefings enable the agency and 
consumers to sustain a dialogue on FDA priorities of high consumer 
interest in the spirit of openness, transparency, and participation. 
This consumer briefing will provide an update on FDA's efforts to 
ensure the safety of products that may contain or are manufactured with 
bovine-derived ingredients.
    Date and Time: The briefing will be held on April 16, 2001, 1 p.m. 
to 4:30 p.m. Registration will open at 12 noon.
    Location: The briefing will be held at Holiday Inn Capitol, 
Columbia II, 550 C St., SW., Washington, DC.
    Contact: Karen R. Mahoney, Office of Consumer Affairs (HFE-88), 
Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 
301-827-4393, FAX 301-827-2866, e-mail: [email protected].
    Registration: Preregistration is required as space is very limited. 
Send registration information (including name, title, organization/firm 
name, address, telephone, fax number and e-mail) to the contact person 
by April 13, 2001. Preregistered consumer attendees will be given first 
priority for seating.
    If you need any special accommodations due to disability, please 
contact Karen R. Mahoney (address above) by April 13, 2001.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents a 
page.

SUPPLEMENTARY INFORMATION: The consumer briefing is an opportunity for 
the agency to meet with consumers and to discuss issues and concerns as 
well as how FDA and consumers can work together to keep consumers 
informed and involved.
    Procedure: The briefing is open to the public. There will be an 
open public session at the conclusion of the briefing where interested 
persons can respond to the topics and issues discussed during the 
briefing.

    Dated: March 27, 2001.
Ann M. Witt,
Acting Associate Commissioner for Policy.
[FR Doc. 01-8062 Filed 4-2-01; 8:45 am]
BILLING CODE 4160-01-S